COPS5 (Jab1) Protein increases β Site processing of amyloid precursor protein and amyloid βpeptide generation by stabilizing ranbp9 protein levels

Journal of Biological Chemistry

Volumn 288, Issue 37, 2013, Pages 26668-26677

  Wang, Hongjie ^a   Dey, Debleena ^b   Carrera, Ivan ^b   Minond, Dmitriy ^c   Bianchi, Elisabetta ^d   Xu, Shaohua ^e   Lakshmana, Madepalli K ^a,c  

^a Section of Neurobiology   (United States)

^b Centro de Investigacion Biomedica EuroEspes   (Spain)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^d INSTITUT PASTEUR   (France)

^e FLORIDA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; AMYLOID PRECURSOR PROTEINS; PROTEIN LEVEL;

PEPTIDES;

GLYCOPROTEINS;

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ALPHA; CARRIER PROTEINS AND BINDING PROTEINS; COMPLEMENTARY DNA; COPS5 PROTEIN; RANBP9 INTERACTING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA CLEAVAGE; DNA HYBRIDIZATION; DNA LIBRARY; DRUG TARGETING; GENE OVEREXPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SPACE; MOUSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

ALZHEIMER'S DISEASE; AMYLOID; AMYLOID PRECURSOR PROTEIN; PROTEIN COMPLEXES; PROTEIN DEGRADATION; PROTEIN STABILITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BINDING SITES; BRAIN; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENE LIBRARY; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; NEURONS; NUCLEAR PROTEINS; PEPTIDE HYDROLASES; PROTEIN BINDING; RNA, SMALL INTERFERING; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84884175104     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.476689     Document Type: Article

References (42)

1. Wimo, A., Winblad, B., and Jonsson, L. (2010) The worldwide societal costs of dementia. Estimates for 2009. Alzheimer's Dement. 6, 98-103
2. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease. Progress and problems on the road to therapeutics. Science 297, 353-356
3. Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R. R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O. A., Jönsson, E. G., Palotie, A., Behrens, T. W., Magnusson, O. T., Kong, A., Thorsteinsdottir, U., Watts, R. J., and Stefansson, K. (2012) A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99
4. Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., and Pedersen, N. L. (2006) Role of genes and environments for explaining Alzheimer's disease. Arch. Gen. Psychiatry 63, 168-174
5. Tanzi, R. E. (2013) A brief history of Alzheimer's disease gene discovery. J. Alzheimer's Dis. 33, 5-13
6. Bird, T. D. (2008) Genetic aspects of Alzheimer's disease. Genet. Med. 10, 231-239
7. Kamboh, M. I., Demirci, F. Y., Wang, X., Minster, R. L., Carrasquillo, M. M., Pankratz, V. S., Younkin, S. G., Saykin, A. J., Alzheimer's Disease Neuroimaging Initiative, Jun, G., Baldwin, C., Logue, M. W., Buros, J., Farrer, L., Pericak-Vance, M. A., Haines, J. L., Sweet, R. A., Ganguli, M., Feingold, E., Dekosky, S. T., Lopez, O. L., and Barmada, M. M. (2012) Genome-wide association study of Alzheimer's disease. Transl. Psychiatry 2, e117
8. Suresh, B., Ramakrishna, S., and Baek, K. H. (2012) Diverse roles of the scaffolding protein RanBPM. Drug Discov. Today 17, 379-387
9. Arefin, A. S., Mathieson, L., Johnstone, D., Berretta, R., and Moscato, P. (2012) Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression. PLoS ONE 7, e45535
10. Lakshmana, M. K., Chung, J. Y., Wickramarachchi, S., Tak, E., Bianchi, E., Koo, E. H., and Kang, D. E. (2010) A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid-βpeptide generation. FASEB J. 24, 119-127
11. Lakshmana, M. K., Yoon, I. S., Chen, E., Bianchi, E., Koo, E. H., and Kang, D. E. (2009) Novel role of RanBP9 in BACE1 processing of amyloid precursor protein and amyloid βpeptide generation. J. Biol. Chem. 284, 11863-11872
12. Lakshmana, M. K., Hayes, C. D., Bennett, S. P., Bianchi, E., Reddy, K. M., Koo, E. H., and Kang, D. E. (2012) Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain. FASEB J. 26, 2072-2083
13. Nishitani, H., Hirose, E., Uchimura, Y., Nakamura, M., Umeda, M., Nishii, K., Mori, N., and Nishimoto, T. (2001) Full-sized RanBPM cDNA encodes a protein processing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex. Gene 272, 25-33
14. Zou, Y., Lim, S., Lee, K., Deng, X., and Friedman, E. (2003) Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M. J. Biol. Chem. 278, 49573-49581
15. Lakshmana, M. K., Chen, E., Yoon, I.-S., and Kang, D. E. (2008) C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65. J. Cell Mol. Med. 12, 2665-2674
16. Bianchi, E., Denti, S., Granata, A., Bossi, G., Geginat, J., Villa, A., Rogge, L., and Pardi, R. (2000) Integrin LFA-1 interacts with the transcriptional coactivator JAB1 to modulate AP-1 activity. Nature 404, 617-621
17. Hayes, C. D., Dey, D., Palavicini, J. P., Wang, H., Araki, W., and Lakshmana, M. K. (2012) Chronic cladribine administration increases amyloidβpeptide generation and plaque burden in mice. PLoS ONE 7, e45841
18. Hayes, C. D., Dey, D., Palavicini, J. P., Wang, H., Patkar, K. A., Minond, D., Nefzi, A., and Lakshmana, M. K. (2013) Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine. BMC Med. 11, 81-96
19. Dugina, V., Zwaenepoel, I., Gabbiani, G., Clément, S., and Chaponnier, C. (2009) ;cytoplasmic actins display distinct distribution and functional diversity. J. Cell Sci. 122, 2980-2988
20. Denti, S., Sirri, A., Cheli, A., Rogge, L., Innamorati, G., Putignano, S., Fabbri, M., Pardi, R., and Bianchi, E. (2004) RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1. J. Biol. Chem. 279, 13027-13034
21. Valiyaveettil, M., Bentley, A. A., Gursahaney, P., Hussien, R., Chakravarti, R., Kureishy, N., Prag, S., and Adams, J. C. (2008) Novel role of the muskelin- RanBP9 complex as a nucleocytoplasmic mediator of cell morphology regulation. J. Cell Biol. 182, 727-739
22. Poirier, M. B., Laflamme, L., and Langlois, M. F. (2006) Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors. J. Mol. Endocrinol. 36, 313-325
23. Chamovitz, D. A., Segal, D. (2001) JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep. 2, 96-101
24. Shackleford, T. J., and Claret, F. X. (2010) JAB1/CSN5.Anew player in cell cycle control and cancer. Cell Div. 5, 26-35
25. Gerlitz, G., Darhin, E., Giorgio, G., Franco, B., and Reiner, O. (2005) Novel functional features of the Lis-H domain. Cell Cycle 4, 1632-1640
26. Tomoda, K., Kubota, Y., and Kato, J. (1999). Degradation of the cyclin dependent-kinase inhibitor p27kip1 is instigated by Jab1. Nature 398, 160-165
27. Bech-Otschir, D., Kraft, R., Huang, X., and Henklein, P. (2001) COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20, 1630-1639
28. Oh, W., Yang, M. R., Lee, E. W., Park, K. M., Pyo, S., Yang, J. S., Lee, H. W., and Song, J. (2006) Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J. Biol. Chem. 281, 30166-30174
29. Wan, M., Cao, X., Wu, Y., and Bai, S. (2002) Jab1 antagonizes TGF-βsignaling by inducing smad4 degradation. EMBO Rep. 3, 171-176
30. Zhou, J., Wan, B., Li, R., Gu, X., Zhong, Z., Wang, Y., and Yu, L. (2012) Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway. Biochem. Biophys. Res. Commun. 422, 647-652
31. Bae, M. K., Ahn, M. Y., Jeong, J. W., Bae, M. H., Lee, Y. M., Bae, S. K., Park, J. W., Kim, K.R., and Kim, K.W. (2002) Jab1 interacts directly with HIF-1βand regulates its stability. J. Biol. Chem. 277, 9-12
32. Tomoda, K., Yoneda-Kato, N., Fukumoto, A., Yamanaka, S., and Kato, J. Y. (2004) Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J. Biol. Chem. 279, 43013-43018
33. Yun, H.-M., Baik, J.-H., Kang, I., Jin, C., and Rhim, H. (2010) Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival. J. Biol. Chem. 285, 10016-10029
34. Cong, S. Y., Pepers, B. A., Zhou, T. T., Kerkdijk, H., Roos, R. A., van Ommen, G. J., and Dorsman, J. C. (2012) Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27 (Kip1) pathway. Neurobiol. Dis. 46, 673-681
35. Schütz, A. K., Hennes, T., Jumpertz, S., Fuchs, S., and Bernhagen, J. (2012) Role of CSN5/JAB1 in Wnt/b-catenin activation in colorectal cancer cells. FEBS Lett. 586, 1645-1651
36. Chen, Y., and Bodles, A. M. (2007) Amyloid precursor protein modulates b-catenin degradation. J. Neuroinflammation 4, 29-37
37. Woo, J. A., Jung, A. R., Lakshmana, M. K., Bedrossian, A., Lim, Y., Bu, J. H., Park, S. A., Koo, E. H., Mook-Jung, I., and Kang, D. E. (2012) Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration. Cell Death Differ. 19, 1413-1423
38. Bu, G., Cam, J., and Zerbinatti, C. (2006) LRP in amyloid- βproduction and metabolism. Ann. N.Y. Acad. Sci. 1086, 35-53
39. Perez, R. G., Soriano, S., Hayes, J. D., Ostaszewski, B., Xia, W., Selkoe, D. J., Chen, X., Stokin, G. B., and Koo, E. H. (1999) Mutagenesis identifies new signals forβ-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42. J. Biol. Chem. 274, 18851-18856
40. Koo, E. H., and Squazzo, S. L. (1994) Evidence that production and release of amyloidβ-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389
41. Perez, O. D., Mitchell, D., Jager, G. C., South, S., Murriel, C., McBride, J., Herzenberg, L. A., Kinoshita, S., and Nolan, G. P. (2003) Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and jun-activating binding protein, Nat. Immunol. 4, 1083-1092
42. Spijkers, P. P., da Costa Martins, P., Westein, E., Gahmberg, C. G., Zwaginga, J. J., and Lenting, P. J. (2005). LDL-receptor-related protein regulates β2-integrin-mediated leucocyte adhesion. Blood 105, 170-177